Newsroom | 4908 results

BALTIMORE--(BUSINESS WIRE)--Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis of metabolic dysfunction by unveiling new research findings during ObesityWeek. Hosted by The Obesity Society in Atlanta, Georgia November 4–7, 2025, the annual conference for obesity researchers and clinicians centers on the latest developments in evidence-based obesity science: cutting-edge basic...

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced the formal launch of the Welldoc AI Lab and confirmed a significant milestone of over 100 peer-reviewed clinical publications, including 43 dedicated to advanced AI. Together with the company's 11 FDA clearances and 60 patents, these achievements underscore Welldoc's unmatched commitment to clinical rigor and evidence-based innovation. Welldoc's AI delivers measurable improvements...

CALGARY, Alberta--(BUSINESS WIRE)--Orpyx® Medical Technologies announced today that its sensory insoles, analytics platform, and remote monitoring program will be used in a new clinical trial funded by the National Institutes of Health (NIH). The WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention study will be led by Johns Hopkins University School of Medicine, with collaborators from Keck Medicine of USC and the University of Utah Spencer Fox Eccles School of Medicine. The $5 mi...

SAN DIEGO--(BUSINESS WIRE)--EASE-Z today introduced EASE-Z Pain Relieving Foot Cream, Diabetic-Safe, for targeted relief from neuropathy symptoms. The new foot cream is the latest offering in the EASE-Z line of products specifically formulated for people with diabetes. Neuropathy or nerve damage is one of the most common complications of diabetes caused by high glucose levels. Diabetic neuropathy results in pain, tingling, numbness or weakness in feet and hands. With its extra-strong over-the-c...

LOS ANGELES--(BUSINESS WIRE)--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, will present leading-edge findings at the 2025 American Society of Hematology (ASH) Annual Meeting and Exposition happening Dec. 6-9 in Orlando and online. Across 105 sessions, City of Hope experts will highlight advances in blood cancer res...

DENVER--(BUSINESS WIRE)--Virta Health, the leader in reversing metabolic disease, has released its inaugural Annual Report on Metabolic Disease Reversal. The report underscores a fundamental truth: the most powerful way to revolutionize healthcare and lower costs is not through disease management, but disease reversal, at scale. Today, 93% of American adults show signs of poor metabolic health.1 With the chronic conditions that follow driving an estimated $1-1.5 trillion of annual U.S. healthca...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Sandra Beaver to its board of directors effective November 7, 2025. Ms. Beaver joins the board as an independent director and will serve on the board’s Audit Committee and Cybersecurity and Data Oversight Committee. “We welcome Sandra to our Board of Directors at this pivotal stage in Tandem’s evolution,” said John Sheridan, presid...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the University of California has received an Agilent Research Catalyst (ARC) award on behalf of Professor Marie Heffern at the UC Davis campus. The award recognizes Professor Heffern’s innovative research into the analytical characterization of peptide and protein therapeutics targeting incretin and related pathways, an emerging area critical to advancing treatments for diabetes and obesity. Professor...

ST. LOUIS--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global life and health reinsurer, published new in-depth research quantifying the mortality and morbidity impacts of incretin-based therapies, including GLP-1s, approved as anti-obesity medications (AOMs) and diabetes treatments. The study examined data from four markets (US, UK, Canada, and Hong Kong) to assess how widespread adoption of AOMs could affect population health outcomes over the next two d...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Android version of the Tandem Mobi mobile app. Tandem Mobi, the world’s smallest, durable automated insulin delivery system 1, is powered by Control-IQ+ technology. Proven Control-IQ+ benefits include: Day 1 improvements2* 79% time in range3† 90% overnight time in range4* “We’re excited...